ea0025p100 | Clinical biochemistry | SFEBES2011
Gupta Saket
, McGowan Lisa
, O'Shea Donal
, Tamagno Gianluca
Somatostatin analogues (SA) represent the most effective medical treatment for the control of neuroendocrine tumour (NET) symptoms, like carcinoid syndrome. Recently there has been evidence of lengthened time to tumour progression in patients with midgut carcinoid treated with octreotide. Nevertheless, a number of new therapeutic indications and the clinical effectiveness of SA for other clinical conditions are appearing. A 69-year-old man was investigated for anaemia (haemogl...